慢性萎缩性胃炎患者消化内科临床治疗剖析.docVIP

慢性萎缩性胃炎患者消化内科临床治疗剖析 　　[摘要] 目的 探讨消化内科规范化治疗在慢性萎缩性胃炎方面的临床治疗效果。 方法 整群选取该院2013年9月―2014年9月期间收治的142例慢性萎缩性胃炎患者作为研究对象，按照随机数字表法将其分为对照组和观察组，对照组患者采取常规治疗，观察组患者在对照组治疗基础上给予替普瑞酮进行治疗，并比较两组患者临床治疗效果。 结果 经过有效治疗，观察组患者显效41例，有效29例，无效1例，总有效率为98.6%，对照组患者显效37例，有效24例，无效10例，总有效率为85.9%，两组比较差异有统计学意义（P0.05）。 结论 在常规药物治疗基础上联合使用替普瑞酮治疗慢性萎缩性胃炎临床效果明显，该方法值得在临床推广应用。 　　[关键词] 消化内科；替普瑞酮；慢性萎缩性胃炎 　　[中图分类号] R59 [文献标识码] A [文章编号] 1674-0742（2015）06（a）-0026-02 　　Clinical Analysis of Treatment for Patients with Chronic Atrophic Gastritis in Department of Gastroenterology 　　WANG Yong 　　Department of Gastroenterology， Zhengzhou People’s Hospital， Zhengzhou， Henan Province， 450000 China 　　[Abstract] Objective To investigate the effect of standardized treatment in Department of Gastroenterology for patients with chronic atrophic gastritis. Methods 142 patients with chronic atrophic gastritis admitted to our hospital between September 2013 and September 2014 were selected as research subjects and divided into control group and observation group according to the random number table. Patients in the control group received the conventional treatment， while those in the observation group were given teprenone treatment on the basis of conventional treatment. Clinical outcomes were compared between the two groups. Results After effective treatment， the observation group were 41 cases markedly effective in 29 cases， 1 case， the total effective rate was 98.6% in the control group were 37 cases markedly effective in 24 cases， 10 cases ineffective， the total effective rate was 85.9% in both groups the difference was statistically significant （P 0.05）. Conclusion The effect of teprenone treatment on the basis of conventional treatment for chronic atrophic gastritis effect is remarkable， so it is worthy of clinical application. 　　[Key words] Gastroenterology； Teprenone； Chronic atrophic gastritis 　　慢性萎缩性胃炎是临床消化内科中较为常见的一种慢性疾病，一般分为自身免疫性和多灶萎缩性胃炎，其临床症状主要表现为恶心、反胃、腹部不适及食欲不振等[1]。慢性萎缩性胃炎发病率较高，且较易反复发作，难以治愈，而且该病若未及时进行治疗，可能转换为胃癌，严重威